MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Tumeric and Curcumin Improve Motor Function and Reduce Catalepsy in a Rotenone -Induced Parkinson’s Disease Model

    L. Darbinyan, L. Hambardzumyan, K. Simonyan, V. Sarkisian, L. Manukyan (Yerevan, Armenia)

    Objective: Catalepsy measurements play a crucial role in behavioral research on Parkinson’s disease (PD), as they reflect significant motor impairments associated with dopaminergic dysfunction. In…
  • 2025 International Congress

    Key components for safer mobility behaviour assessment and intervention for people with Parkinson’s disease: A modified Delphi study

    D. Cheung, S. Paul, L. Mackenzie, J. Wesson, N. Allen (Camperdown, Australia)

    Objective: To develop a consensus-based summary of key components that people with lived experience, clinicians and researchers find important to include in an assessment tool…
  • 2025 International Congress

    Spatiotemporal Gait Norms in Moderate-to-Advanced Parkinson’s Disease

    K. Miller, R. Tripathi, S. Solano, S. Factor, J. Mckay, C. Esper (Atlanta, USA)

    Objective: Understanding gait abnormalities in moderate-to-advanced Parkinson’s disease (PD) is essential to enhance patient mobility and optimize clinical management [1]. This study aims to establish…
  • 2025 International Congress

    The Effect of Melatonin on Sleep Quality and Daytime Sleepiness in Parkinson’s Disease: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials

    A. Zrineh, R. Akwan, MM. Elsharkawy, B. Douden, W. Sleibi, M. Eldesouki (Al-Quds, State of Palestine)

    Objective: This study aims to systematically quantify the impact of melatonin on sleep quality and daytime sleepiness in individuals diagnosed with Parkinson’s disease (PD). Background:…
  • 2025 International Congress

    Is It Better to Sing Together? A Review of Choral Singing for People with Parkinson’s Disease

    S. Kolipaka, H. Kong, P. Izbicki (Boca Raton, USA)

    Objective: This review assesses the effects of choral singing as an adjunct therapy for Parkinson’s disease (PD). Background: PD is the second-most common neurodegenerative disease,…
  • 2025 International Congress

    Addressing Sex and Gender Gaps in Parkinson’s Research: A Multi-Stakeholder Approach

    L. Smith, S. Hussain-Ali, R. Flanagan, C. Carroll, M. Auffret (London, United Kingdom)

    Objective: To describe and address sex and gender gaps in Parkinson’s disease (PD) research through a multidisciplinary, multi-stakeholder approach that includes patient representatives, researchers, clinicians,…
  • 2025 International Congress

    Non-motor Symptoms in Parkinson Disease: A Target for Neuropalliative Care Intervention

    J. Acquaviva, S. Maguire, Y. Xu, E. Feinstein (Newark, USA)

    Objective: To identify various non-motor symptoms experienced by individuals with PD and to assess the likelihood of these symptoms being treated relative to individuals without…
  • 2025 International Congress

    Impact of Gastrointestinal Dysfunction Symptoms on Psychomotor Recovery Following 8-Week Aerobic Interval Training in Parkinson’s Disease – Preliminary Results

    K. Lorek, K. Markowska, A. Bereza, E. Koziorowska, S. Budrewicz, P. Nowakowski, S. Chomiak (Wroclaw, Poland)

    Objective: To investigate the impact of gastrointestinal dysfunction symptoms (GIDS) on psychomotor recovery following 8-week aerobic interval training (AIT) in Parkinson's disease (PD). Background: GIDS…
  • 2025 International Congress

    Impact of ND0612 on Levodopa-Induced Dyskinesia in Parkinson’s Disease: Post hoc Analyses From a Randomized, Active-Controlled Study

    A. Ellenbogen, R. Pahwa, J. Hernández-Vara, N. Lopes, J. Pereira, A. Espay (Farmington Hills, USA)

    Objective: To evaluate dyskinesia-related outcomes between optimized subcutaneously administered levodopa/carbidopa (ND0612) + immediate-release levodopa/carbidopa (IR-LD/CD) vs optimized oral IR-LD/CD in patients with Parkinson’s disease (PD).…
  • 2025 International Congress

    A Phase I Study of TR-012001, a Nasal Levodopa, in Healthy Adult Japanese Male Subjects

    R. Ise, M. Kaneko, S. Haruta, Y. Sonoda, Y. Akiyoshi, C. Date, S. Nakano, T. Akagi, Y. Sumiyoshi, S. Kanazashi, I. Nagata, H. Fukase (Tokyo, Japan)

    Objective: To investigate the safety, tolerability, and pharmacokinetics of TR-012001, a nasal levodopa (LD), in healthy Japanese adult men with and without premedication with dopa…
  • « Previous Page
  • 1
  • …
  • 150
  • 151
  • 152
  • 153
  • 154
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley